510 related articles for article (PubMed ID: 11795443)
21. Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
Goss PE; Strasser K
Drugs; 2002; 62(6):957-66. PubMed ID: 11929341
[TBL] [Abstract][Full Text] [Related]
22. Optimizing the antihormonal treatment and prevention of breast cancer.
Patel RR; Sharma CG; Jordan VC
Breast Cancer; 2007; 14(2):113-22. PubMed ID: 17485895
[TBL] [Abstract][Full Text] [Related]
23. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
Trunet P; Marty M
Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
[TBL] [Abstract][Full Text] [Related]
24. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
25. Progress in chemoprevention of breast cancer.
Serrano D; Perego E; Costa A; Decensi A
Crit Rev Oncol Hematol; 2004 Feb; 49(2):109-17. PubMed ID: 15012972
[TBL] [Abstract][Full Text] [Related]
26. Chemoprevention of breast cancer.
O'Shaughnessy JA
JAMA; 1996 May; 275(17):1349-53. PubMed ID: 8614122
[No Abstract] [Full Text] [Related]
27. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
Johnston SR
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
[TBL] [Abstract][Full Text] [Related]
28. The selective estrogen receptor modulators in breast cancer prevention.
Li F; Dou J; Wei L; Li S; Liu J
Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
[TBL] [Abstract][Full Text] [Related]
29. Chemoprevention with antiestrogens: the beginning of the end for breast cancer. Daniel G. Miller Lecture.
Jordan VC
Ann N Y Acad Sci; 2001 Dec; 952():60-72. PubMed ID: 11795444
[TBL] [Abstract][Full Text] [Related]
30. Chemoprevention Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials.
Salazar AS; Rakhmankulova M; Simon LE; Toriola AT
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33554041
[TBL] [Abstract][Full Text] [Related]
31. Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs).
Lo SS; Vogel VG
Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):97-111. PubMed ID: 14687600
[TBL] [Abstract][Full Text] [Related]
32. Prevention of hormone-related cancers: breast cancer.
Dunn BK; Wickerham DL; Ford LG
J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
[TBL] [Abstract][Full Text] [Related]
33. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
Wu K; Brown P
J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921
[No Abstract] [Full Text] [Related]
34. Breast cancer prevention--clinical trials strategies involving aromatase inhibitors.
Goss PE
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):487-93. PubMed ID: 14623548
[TBL] [Abstract][Full Text] [Related]
35. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
Baumann CK; Castiglione-Gertsch M
Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer prevention with selective estrogen receptor modulators: a perspective.
Pritchard KI
Ann N Y Acad Sci; 2001 Dec; 949():89-98. PubMed ID: 11795385
[TBL] [Abstract][Full Text] [Related]
37. Risks versus benefits in the clinical application of aromatase inhibitors.
Goss PE
Endocr Relat Cancer; 1999 Jun; 6(2):325-32. PubMed ID: 10731126
[TBL] [Abstract][Full Text] [Related]
38. Risk-reducing strategies for breast cancer--a review of recent literature.
Mokbel K
Int J Fertil Womens Med; 2003; 48(6):274-7. PubMed ID: 15646397
[TBL] [Abstract][Full Text] [Related]
39. The potential of aromatase inhibitors in breast cancer prevention.
Santen RJ; Yue W; Naftolin F; Mor G; Berstein L
Endocr Relat Cancer; 1999 Jun; 6(2):235-43. PubMed ID: 10731115
[TBL] [Abstract][Full Text] [Related]
40. Prevention of breast cancer using SERMs and aromatase inhibitors.
Strassmer-Weippl K; Goss PE
J Mammary Gland Biol Neoplasia; 2003 Jan; 8(1):5-18. PubMed ID: 14587860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
